Choose Your Location
|
![]() |
NEW YORK (Map) -
SGI Co-Founder
Founded in 1989, SGI is headed by
About AMDL
AMDL, Inc. is a global specialty pharmaceutical company. The Company is
headquartered in
Forward-Looking Statements
The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by the Company or on its behalf. This news release contains forward-looking statements, which are subject to certain risks and uncertainties that can cause actual results to differ materially from those described. Factors that may cause such differences include, but are not limited to, uncertainties relating to our ability to successfully complete Phase III clinical trials and secure regulatory approval of our current or future drug-delivery system and uncertainties regarding our ability to obtain financial and other resources for any research, development and commercialization activities. These factors, and others, are discussed from time to time in our filings with the Securities and Exchange Commission. You should not place undue reliance on these forward-looking statements, which speak only as of the date they are made. We undertake no obligation to publicly update or revise these forward-looking statements to reflect events or circumstances after the date they are made.
AMDL Contact: Investor Relations Contact: Kristine Szarkowitz Strategic Growth International, Inc. Director-Investor Relations Richard E. Cooper - rcooper@sgi-ir.com kszarkowitz@amdl.com Cass Almendral - cass@sgi-ir.com (206) 310-5323 (212) 838-1444/ http://www.sgi-ir.com
|
|


